In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Expected publication date

Expected publication date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 91 to 100 of 391

TitleTypeExpected publication date
Delgocitinib for treating moderate to severe chronic hand eczema [ID6408]Technology appraisal guidance
Depemokimab for treating chronic rhinosinusitis with nasal polyps [ID6449]Technology appraisal guidanceTBC
Depemokimab for treating severe eosinophilic asthma in people 12 years and over [ID6447]Technology appraisal guidance
Dersimelagon for treating erythropoietic protoporphyria and X-linked protoporphyria in people 12 years and over [ID6160]Technology appraisal guidanceTBC
Deuruxolitinib for treating severe alopecia areata ID6597Technology appraisal guidanceTBC
Deutetrabenazine for treating tardive dyskinesia ID6550Technology appraisal guidanceTBC
Dexmedetomidine for treating agitation associated with bipolar disorder in people 18 to 75 years [TS ID 10725]Technology appraisal guidanceTBC
Dexmedetomidine for treating agitation associated with schizophrenia TS ID 10726Technology appraisal guidanceTBC
Diabetes in pregnancy: management from preconception to the postnatal period - Managing type 1 diabetes (T1D) using hybrid closed loops (update)NICE guidelineTBC
Diabetic retinopathy - ruboxistaurin [ID382]Technology appraisal guidanceTBC

Results per page

  1. 10
  2. 25
  3. 50
  4. All